Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension Response

Circulation - United States
doi 10.1161/01.cir.100.6.685
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Effect of Angiotensin II AT1 Antagonist, Candesartan on Left Ventricular Hypertrophy and Glucose Tolerance in Essential Hypertension Patient.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1999English

Angiotensin II Receptor Blockade With Valsartan Decreases Plasma Osteopontin Levels in Patients With Essential Hypertension

Journal of Human Hypertension
Internal Medicine
2010English

Left Ventricular Hypertrophy and Arterial Stiffness in Essential Hypertension

Bratislava Medical Journal
2015English

Ventricular Premature Contraction in Hypertrophic Cardiomyopathy and Essential Hypertension With Left Ventricular Hypertrophy

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1989English

Role of Cardiac Angiotensin II in Isoproterenol-Induced Left Ventricular Hypertrophy.

Hypertension
Internal Medicine
1992English

Influence of Hypertension, Left Ventricular Hypertrophy, and Left Ventricular Systolic Dysfunction on Plasma N Terminal proBNP

Heart
2000English

Alteration of Carotid Circulation in Essential Hypertensive Patients With Left Ventricular Hypertrophy

Journal of Human Hypertension
Internal Medicine
1998English

Cardiopulmonary Reflex Before and After Regression of Left Ventricular Hypertrophy in Essential Hypertension

Hypertension
Internal Medicine
1988English

Left Ventricular Hypertrophy in Hypertension: Its Arrhythmogenic Potential

Heart
Cardiovascular MedicineCardiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy